ENA Sectors 2025-10-07 17:24:39 <p><span style="font-size:14px"><strong>New Delhi, Oct 7 (KNN)</strong> Eli Lilly, the U.S.-based pharmaceutical giant, has announced plans to invest over $1 billion in India over the coming years.</span></p> <p><span style="font-size:14px">This move aims to strengthen contract manufacturing and supply chain capabilities through partnerships with local drugmakers.</span></p> <p><span style="font-size:14px">A major part of this investment will be the establishment of a new manufacturing and global medicine supply hub in Hyderabad. The facility will serve as a central point to oversee and enhance Lillys contract manufacturing network across India, supporting the production of essential medicines for various conditions.</span></p> <p><span style="font-size:14px">Patrik Jonsson, President of Lilly International, said the initiative highlights the companys commitment to expanding global manufacturing capacity and ensuring medicines are widely available.</span></p> <p><span style="font-size:14px">The Hyderabad facility is expected to support the production of treatments for diabetes, obesity, Alzheimers disease, cancer, and autoimmune disorders, leveraging Indias skilled workforce.</span></p> <p><span style="font-size:14px">Recruitment for the new facility will begin immediately, with positions open for engineers, chemists, analytical scientists, quality control and assurance professionals, and management staff.</span></p> <p><span style="font-size:14px">This expansion follows the opening of a global capability center (GCC) in Hyderabad just a year ago, demonstrating Lillys growing presence in India.</span></p> <p><span style="font-size:14px">Although Eli Lilly does not currently operate its own manufacturing facility in India, the company has committed $55 billion globally to build, expand, and acquire facilities.</span></p> <p><span style="font-size:14px">The investment reflects a strategic focus on strengthening manufacturing and supply chains to meet rising global demand.</span></p> <p><span style="font-size:14px">India, known for its robust pharmaceutical sector and skilled workforce, continues to attract major global pharma investments. Eli Lillys $1 billion plan is part of a broader trend of multinational drugmakers boosting production capabilities in the country to ensure timely access to critical medicines worldwide.</span></p> <p><em><strong><span style="font-size:14px">(KNN Bureau)</span></strong></em></p> 43733 https://knnindia.co.in/news/newsdetails/sectors/eli-lilly-to-invest-1-billion-in-india-to-boost-contract-manufacturing-and-global-medicine-supply 2025-10-07 17:24:39 knnindia.co.in